174 related articles for article (PubMed ID: 30145120)
1. Prediction of the Risk of Malignancy Among Detected Lung Nodules in the National Lung Screening Trial.
Hassannezhad R; Vahed N
J Am Coll Radiol; 2018 Nov; 15(11):1529-1535. PubMed ID: 30145120
[TBL] [Abstract][Full Text] [Related]
2. Predicting Malignancy Risk of Screen-Detected Lung Nodules-Mean Diameter or Volume.
Tammemagi M; Ritchie AJ; Atkar-Khattra S; Dougherty B; Sanghera C; Mayo JR; Yuan R; Manos D; McWilliams AM; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Seely JM; Burrowes P; Bhatia R; Haider EA; Boylan C; Jacobs C; van Ginneken B; Tsao MS; Lam S;
J Thorac Oncol; 2019 Feb; 14(2):203-211. PubMed ID: 30368011
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of automated lung nodule detection on low-dose computed tomography scans from a lung cancer screening program(1).
Armato SG; Roy AS; Macmahon H; Li F; Doi K; Sone S; Altman MB
Acad Radiol; 2005 Mar; 12(3):337-46. PubMed ID: 15766694
[TBL] [Abstract][Full Text] [Related]
5. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
[TBL] [Abstract][Full Text] [Related]
7. The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort.
White CS; Dharaiya E; Campbell E; Boroczky L
Radiology; 2017 Apr; 283(1):264-272. PubMed ID: 27740906
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
10. Early detection of lung cancer using ultra-low-dose computed tomography in coronary CT angiography scans among patients with suspected coronary heart disease.
Zanon M; Pacini GS; de Souza VVS; Marchiori E; Meirelles GSP; Szarf G; Torres FS; Hochhegger B
Lung Cancer; 2017 Dec; 114():1-5. PubMed ID: 29173759
[TBL] [Abstract][Full Text] [Related]
11. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
[TBL] [Abstract][Full Text] [Related]
12. Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial.
Nair VS; Sundaram V; Gould MK; Desai M
Chest; 2016 Sep; 150(3):621-30. PubMed ID: 27179906
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
[TBL] [Abstract][Full Text] [Related]
14. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
Heuvelmans MA; Walter JE; Peters RB; Bock GH; Yousaf-Khan U; Aalst CMV; Groen HJM; Nackaerts K; Ooijen PMV; Koning HJ; Oudkerk M; Vliegenthart R
Lung Cancer; 2017 Nov; 113():45-50. PubMed ID: 29110848
[TBL] [Abstract][Full Text] [Related]
15. Results of the two incidence screenings in the National Lung Screening Trial.
Aberle DR; DeMello S; Berg CD; Black WC; Brewer B; Church TR; Clingan KL; Duan F; Fagerstrom RM; Gareen IF; Gatsonis CA; Gierada DS; Jain A; Jones GC; Mahon I; Marcus PM; Rathmell JM; Sicks J;
N Engl J Med; 2013 Sep; 369(10):920-31. PubMed ID: 24004119
[TBL] [Abstract][Full Text] [Related]
16. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
[TBL] [Abstract][Full Text] [Related]
17. The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules.
van 't Westeinde SC; Horeweg N; Vernhout RM; Groen HJM; Lammers JJ; Weenink C; Nackaerts K; Oudkerk M; Mali W; Thunnissen FB; de Koning HJ; van Klaveren RJ
Chest; 2012 Aug; 142(2):377-384. PubMed ID: 22302298
[TBL] [Abstract][Full Text] [Related]
18. Ability of low-dose helical CT to distinguish between benign and malignant noncalcified lung nodules.
Markowitz SB; Miller A; Miller J; Manowitz A; Kieding S; Sider L; Morabia A
Chest; 2007 Apr; 131(4):1028-34. PubMed ID: 17426206
[TBL] [Abstract][Full Text] [Related]
19. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.
Walter JE; Heuvelmans MA; de Bock GH; Yousaf-Khan U; Groen HJM; van der Aalst CM; Nackaerts K; van Ooijen PMA; de Koning HJ; Vliegenthart R; Oudkerk M
Lung Cancer; 2018 Nov; 125():103-108. PubMed ID: 30429006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
